Published in Nature on May 27, 2010
Metabolism of Deuterated NNN in Smokeless Tobacco Users | NCT02414477
A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36
Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
The genomic complexity of primary human prostate cancer. Nature (2011) 14.06
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
A landscape of driver mutations in melanoma. Cell (2012) 12.61
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Frequent pathway mutations of splicing machinery in myelodysplasia. Nature (2011) 11.44
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet (2010) 10.15
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Accurate and comprehensive sequencing of personal genomes. Genome Res (2011) 8.99
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature (2012) 8.03
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature (2012) 7.76
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet (2011) 5.68
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet (2011) 5.67
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63
The genetic landscape of high-risk neuroblastoma. Nat Genet (2013) 4.71
Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature (2012) 3.92
The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res (2012) 3.80
The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72
The genetic architecture of multiple myeloma. Nat Rev Cancer (2012) 3.71
Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Genet (2014) 3.52
Variation in the mutation rate across mammalian genomes. Nat Rev Genet (2011) 3.09
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2. Proc Natl Acad Sci U S A (2012) 3.06
Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet (2014) 2.86
Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer (2011) 2.77
Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol (2011) 2.64
Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer (2011) 2.64
High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nat Biotechnol (2011) 2.63
Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell (2012) 2.61
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol (2013) 2.59
Landscape of next-generation sequencing technologies. Anal Chem (2011) 2.58
Revisiting Mendelian disorders through exome sequencing. Hum Genet (2011) 2.57
ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell (2010) 2.50
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012) 2.41
Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet (2010) 2.39
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res (2013) 2.27
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity. BMC Med Genomics (2011) 2.24
The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. Genome Res (2012) 2.19
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol (2011) 2.10
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A (2013) 2.09
Lung carcinogenesis by tobacco smoke. Int J Cancer (2012) 2.06
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell (2013) 2.00
Lung cancer cell lines as tools for biomedical discovery and research. J Natl Cancer Inst (2010) 1.92
Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res (2011) 1.90
Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol Rev (2014) 1.86
Error-prone translesion synthesis mediates acquired chemoresistance. Proc Natl Acad Sci U S A (2010) 1.85
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis (2012) 1.84
The cancer antigenome. EMBO J (2012) 1.78
Overcoming bias and systematic errors in next generation sequencing data. Genome Med (2010) 1.75
DNA replication fidelity and cancer. Semin Cancer Biol (2010) 1.69
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. J Pathol (2012) 1.67
Molecular biology of lung cancer. J Thorac Dis (2013) 1.67
Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67
The role of replicates for error mitigation in next-generation sequencing. Nat Rev Genet (2013) 1.66
Evidence of non-random mutation rates suggests an evolutionary risk management strategy. Nature (2012) 1.56
Cancer genome-sequencing study design. Nat Rev Genet (2013) 1.55
Conserved recurrent gene mutations correlate with pathway deregulation and clinical outcomes of lung adenocarcinoma in never-smokers. BMC Med Genomics (2014) 1.53
Existing and emerging technologies for tumor genomic profiling. J Clin Oncol (2013) 1.52
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms. Leukemia (2013) 1.51
LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma. Proc Natl Acad Sci U S A (2015) 1.49
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res (2012) 1.47
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat Genet (2015) 1.45
DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat Commun (2012) 1.40
Comparing somatic mutation-callers: beyond Venn diagrams. BMC Bioinformatics (2013) 1.35
Chromium in drinking water: sources, metabolism, and cancer risks. Chem Res Toxicol (2011) 1.34
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study. PLoS Biol (2014) 1.34
Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol (2012) 1.33
Short read alignment with populations of genomes. Bioinformatics (2013) 1.30
Environmental exposures and mutational patterns of cancer genomes. Genome Med (2010) 1.29
Technology-specific error signatures in the 1000 Genomes Project data. Hum Genet (2011) 1.27
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res (2012) 1.27
Identification of genetic association of multiple rare variants using collapsing methods. Genet Epidemiol (2011) 1.26
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity. Genome Biol (2011) 1.25
Evolution of the cancer genome. Trends Genet (2012) 1.22
Genomic evidence for elevated mutation rates in highly expressed genes. EMBO Rep (2012) 1.19
Roles for the transcription elongation factor NusA in both DNA repair and damage tolerance pathways in Escherichia coli. Proc Natl Acad Sci U S A (2010) 1.18
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
Translating genomic information into clinical medicine: lung cancer as a paradigm. Genome Res (2012) 1.18
Detection of base substitution-type somatic mosaicism of the NLRP3 gene with >99.9% statistical confidence by massively parallel sequencing. DNA Res (2012) 1.16
COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing. Clin Chem (2011) 1.14
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics (2013) 1.13
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene (2011) 1.13
DREM 2.0: Improved reconstruction of dynamic regulatory networks from time-series expression data. BMC Syst Biol (2012) 1.11
Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration. Cancer Cytopathol (2011) 1.11
Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas. Cancer (2012) 1.10
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database (Oxford) (2014) 1.10
Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology (2012) 1.09
Binary complex crystal structure of DNA polymerase β reveals multiple conformations of the templating 8-oxoguanine lesion. Proc Natl Acad Sci U S A (2011) 1.09
A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers. PLoS One (2013) 1.08
Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges. Cancer Discov (2011) 1.07
Translating cancer 'omics' to improved outcomes. Genome Res (2012) 1.07
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Circos: an information aesthetic for comparative genomics. Genome Res (2009) 40.02
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature (2007) 37.09
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
The cancer genome. Nature (2009) 23.13
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science (2009) 21.24
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet (2008) 16.09
Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature (1973) 15.28
Lung cancer. N Engl J Med (2008) 13.49
The Human Gene Mutation Database: 2008 update. Genome Med (2009) 11.72
Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst (1999) 8.59
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res (2007) 6.91
Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res (2006) 4.25
Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res (2009) 2.65
Lung cancer preneoplasia. Annu Rev Pathol (2006) 2.04
Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol (2003) 1.72
Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol (2002) 1.57
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell (2006) 21.66
Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science (2009) 21.24
Whole-genome patterns of common DNA variation in three human populations. Science (2005) 21.22
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood (2003) 20.10
An extensible application for assembling annotation for genomic data. Bioinformatics (2003) 18.95
Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science (2010) 18.45
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature (2010) 15.63
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem (2002) 14.34
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med (2008) 12.68
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
The PredictProtein server. Nucleic Acids Res (2004) 10.89
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J Clin Oncol (2005) 9.95
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61
Using the transcriptome to annotate the genome. Nat Biotechnol (2002) 9.04
Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85
ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics (2009) 8.69
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med (2009) 8.55
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet (2008) 8.44
Software for computing and annotating genomic ranges. PLoS Comput Biol (2013) 8.20
A paracrine requirement for hedgehog signalling in cancer. Nature (2008) 8.16
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res (2008) 8.12
Shotgun sequence assembly and recent segmental duplications within the human genome. Nature (2004) 7.91
Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90
PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res (2013) 7.63
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med (2009) 7.23
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol (2006) 6.82
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
arrayQualityMetrics--a bioconductor package for quality assessment of microarray data. Bioinformatics (2008) 5.95
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature (2011) 5.45
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science (2009) 5.40
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature (2011) 5.32
Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov (2006) 5.30
Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A (2010) 5.21
Recurrent R-spondin fusions in colon cancer. Nature (2012) 5.10
Fine-scale recombination patterns differ between chimpanzees and humans. Nat Genet (2005) 5.00
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet (2004) 4.95
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res (2005) 4.94
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science (2011) 4.76
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet (2012) 4.70
Genomewide SNP variation reveals relationships among landraces and modern varieties of rice. Proc Natl Acad Sci U S A (2009) 4.65
The genome of M. acetivorans reveals extensive metabolic and physiological diversity. Genome Res (2002) 4.58
PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect Immun (2011) 4.57
Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci U S A (2011) 4.55
Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science (2010) 4.52
Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell (2009) 4.47
Extensions to gene set enrichment. Bioinformatics (2006) 4.26
The External RNA Controls Consortium: a progress report. Nat Methods (2005) 4.24
Leaf nitrogen and phosphorus stoichiometry across 753 terrestrial plant species in China. New Phytol (2005) 4.20